Semel Institute for Neuroscience and Human Behavior

Last updated

The Semel Institute for Neuroscience and Human Behavior is a research institute of the University of California Los Angeles (UCLA). It includes a number of centers, including the "Center for Neurobehavioral Genetics", which uses DNA sequencing, gene expression studies, bioinformatics, and the genetic manipulation of model organisms to understand brain and behavioral phenotypes.

Contents

History

The UCLA Neuropsychiatric Institute and Hospital opened in 1961, consisting of The UCLA Neuropsychiatric Institute (NPI) and the UCLA Neuropsychiatric Hospital (NPH). It was in charge of the Department of Psychiatry and the Department of Neurology, and Neurosurgery and Neuropathology services. In 1973, NPI resources were transferred to the university, the institute became part of the Health Sciences, and the Department of Neurology became independent.

In 2004, the institute was renamed the Jane & Terry Semel Institute for Neuroscience and Human Behavior, and the Stewart & Lynda Resnick Neuropsychiatric Hospital at UCLA was established. [1]

Integrative Phenotyping Center for Neuropsychiatry

The institute plans to use a $14.9 million stimulus grant to create "The Integrative Phenotyping Center for Neuropsychiatry", a new interdisciplinary research center focused on the role of genetic and environmental factors in neuropsychiatric and behavioral disorders. This center is in the design phase and is expected to be under construction in 2011 and ready for occupancy in late 2012. [2] It will employ around 180 employees and it will be housed in a 33,000-square-foot (3,100 m2) space covering three renovated floors of the current Semel Institute tower. It will use a National Institutes of Health grant, funded through the American Recovery and Reinvestment Act of 2009, for research on autism, attention deficit disorder, schizophrenia, major depressive disorder, bipolar disorder, and Alzheimer's disease and other dementias. The facility will enable large-scale studies, including studies of personality, cognition, and brain activity and structure. "This project is completed." [3]

See also

Related Research Articles

<span class="mw-page-title-main">National Institute of Neurological Disorders and Stroke</span> Department of the U.S. National Institutes of Health

The National Institute of Neurological Disorders and Stroke (NINDS) is a part of the U.S. National Institutes of Health (NIH). It conducts and funds research on brain and nervous system disorders and has a budget of just over US$2.03 billion. The mission of NINDS is "to reduce the burden of neurological disease—a burden borne by every age group, every segment of society, and people all over the world". NINDS has established two major branches for research: an extramural branch that funds studies outside the NIH, and an intramural branch that funds research inside the NIH. Most of NINDS' budget goes to fund extramural research. NINDS' basic science research focuses on studies of the fundamental biology of the brain and nervous system, genetics, neurodegeneration, learning and memory, motor control, brain repair, and synapses. NINDS also funds clinical research related to diseases and disorders of the brain and nervous system, e.g. AIDS, Alzheimer's disease, epilepsy, muscular dystrophy, multiple sclerosis, Parkinson's disease, spinal cord injury, stroke, and traumatic brain injury.

The UC Davis MIND Institute is a research and treatment center affiliated with the University of California, Davis, with facilities located on the UC Davis Medical Center campus in Sacramento, California. The institute is a consortium of scientists, educators, physicians and parents dedicated to researching the causes of and treatments for autism spectrum disorders, fragile X syndrome, and other neurodevelopmental disorders. The director of the MIND institute is Dr. Leonard Abbeduto.

<span class="mw-page-title-main">Institute of Psychiatry, Psychology and Neuroscience</span> Research institution in London, England

The Institute of Psychiatry, Psychology & Neuroscience (IoPPN) is a leading centre for mental health and neuroscience research, education and training in Europe. It is dedicated to understanding, preventing and treating mental illness, neurological conditions, and other conditions that affect the brain. The IoPPN is a faculty of King's College London, England, and was previously known as the Institute of Psychiatry (IoP).

Neuropsychiatry is a branch of medicine that deals with psychiatry as it relates to neurology, in an effort to understand and attribute behavior to the interaction of neurobiology and social psychology factors. Within neuropsychiatry, the mind is considered "as an emergent property of the brain", whereas other behavioral and neurological specialties might consider the two as separate entities. Those disciplines are typically practiced separately.

<span class="mw-page-title-main">Heritability of autism</span>

The heritability of autism is the proportion of differences in expression of autism that can be explained by genetic variation; if the heritability of a condition is high, then the condition is considered to be primarily genetic. Autism has a strong genetic basis. Although the genetics of autism are complex, autism spectrum disorder (ASD) is explained more by multigene effects than by rare mutations with large effects.

<span class="mw-page-title-main">Neurogenetics</span>

Neurogenetics studies the role of genetics in the development and function of the nervous system. It considers neural characteristics as phenotypes, and is mainly based on the observation that the nervous systems of individuals, even of those belonging to the same species, may not be identical. As the name implies, it draws aspects from both the studies of neuroscience and genetics, focusing in particular how the genetic code an organism carries affects its expressed traits. Mutations in this genetic sequence can have a wide range of effects on the quality of life of the individual. Neurological diseases, behavior and personality are all studied in the context of neurogenetics. The field of neurogenetics emerged in the mid to late 20th century with advances closely following advancements made in available technology. Currently, neurogenetics is the center of much research utilizing cutting edge techniques.

<span class="mw-page-title-main">Susan Smalley</span> American geneticist

Susan Smalley is an American behavioral geneticist, writer and activist. The co-author of Fully Present: The Science, Art, and Practice of Mindfulness, she is the founder of the UCLA Mindful Awareness Research Center at the Jane and Terry Semel Institute for Neuroscience and Human Behavior (MARC), and professor emerita in the department of psychiatry and biobehavioral sciences at UCLA. Her research centers on the genetic basis of childhood-onset behavior disorders, such as ADHD, and the cognitive and emotional impact of mindfulness meditation on health and wellbeing. She has published more than 100 peer-reviewed papers and lectured globally on the genetics of human behavior and the science of mindfulness.

Some of the research that is conducted in the field of psychology is more "fundamental" than the research conducted in the applied psychological disciplines, and does not necessarily have a direct application. The subdisciplines within psychology that can be thought to reflect a basic-science orientation include biological psychology, cognitive psychology, neuropsychology, and so on. Research in these subdisciplines is characterized by methodological rigor. The concern of psychology as a basic science is in understanding the laws and processes that underlie behavior, cognition, and emotion. Psychology as a basic science provides a foundation for applied psychology. Applied psychology, by contrast, involves the application of psychological principles and theories yielded up by the basic psychological sciences; these applications are aimed at overcoming problems or promoting well-being in areas such as mental and physical health and education.

<span class="mw-page-title-main">Huda Zoghbi</span> Lebanese scientist

Huda Yahya Zoghbi, born Huda El-Hibri, is a Lebanese-born American geneticist, and a professor at the Departments of Molecular and Human Genetics, Neuroscience and Neurology at the Baylor College of Medicine. She is the director of the Jan and Dan Duncan Neurological Research Institute. She became the editor of the Annual Review of Neuroscience as of 2018.

<span class="mw-page-title-main">Wim Crusio</span> Dutch behavioral neurogeneticist

Wim E. Crusio is a Dutch behavioral neurogeneticist and a directeur de recherche with the French National Centre for Scientific Research in Talence, France.

Cognitive genomics is the sub-field of genomics pertaining to cognitive function in which the genes and non-coding sequences of an organism's genome related to the health and activity of the brain are studied. By applying comparative genomics, the genomes of multiple species are compared in order to identify genetic and phenotypical differences between species. Observed phenotypical characteristics related to the neurological function include behavior, personality, neuroanatomy, and neuropathology. The theory behind cognitive genomics is based on elements of genetics, evolutionary biology, molecular biology, cognitive psychology, behavioral psychology, and neurophysiology.

Paul Thompson is a professor of neurology at the Imaging Genetics Center at the University of Southern California. Thompson obtained a bachelor's degree in Greek and Latin languages and mathematics from Oxford University. He also earned a master's degree in mathematics from Oxford and a PhD degree in neuroscience from University of California, Los Angeles.

Martien J.H. Kas is associate professor in the Department of Translational Neuroscience, Brain Center Rudolf Magnus, at the University Medical Center Utrecht, where he leads a work group entitled "Translational Behavioral Genetics" that researches cross-species behavioral genetics to better understand origins and develop treatments for psychiatric disorders.

<span class="mw-page-title-main">Lori L. Altshuler</span> American psychiatrist

Lori Altshuler was a professor at the University of California, Los Angeles (UCLA) Department of Psychiatry and Biobehavioral Sciences and held the Julia S. Gouw Endowed Chair for Mood Disorders. Altshuler was the Director of the UCLA Mood Disorders Research Program and the UCLA Women's Life Center, each being part of the Neuropsychiatric Hospital at UCLA.

Charles L. Raison is an American psychiatrist and professor of psychiatry at the University of Wisconsin-Madison School of Medicine and Public Health as well as the Mary Sue and Mike Shannon Chair for Healthy Minds, Children & Families and Professor with the School of Human Ecology in Madison, Wisconsin.

Jonathan Flint is a British behavior geneticist and Professor in Residence in the Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine at UCLA. He is also a senior scientist in the Center for Neurobehavioral Genetics at UCLA's Semel Institute for Neuroscience and Human Behavior.

Anne M. Andrews is an American academic, the Richard Metzner Endowed Chair in Clinical Neuropharmacology, Professor of Chemistry & Biochemistry, and Professor of Psychiatry & Behavioral Sciences at the University of California, Los Angeles. Andrews is known for her work on the study of the serotonin system with a special focus on how the serotonin transporter modulates complex behaviors including anxiety, mood, stress responsiveness, and learning and memory.

Stephanie Ann White is an American neuroscientist who is a professor at the University of California, Los Angeles. Her research looks to understand how social interactions impact the brain. She serves as Director of the Neural Systems and Behavior programme at the Marine Biological Laboratory.

Carrie Elyse Bearden is an American psychologist and academic. She is a professor at the David Geffen School of Medicine, University of California, Los Angeles, and Director of the UCLA Center for the Assessment and Prevention of Prodromal States, a clinical research program for youth at high risk for psychotic disorders. She is most known for her research taking a ‘genetics first’ approach to study brain mechanisms underlying the development of serious mental illness. Her work has identified biological convergence between genetically and clinically defined high-risk populations.

References

  1. "About the Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA".
  2. "Semel Institute awarded $15M to establish new integrative phenotyping center". EurekAlert!.
  3. "Semel Construction". Archived from the original on 2017-09-30. Retrieved 2017-09-30.

34°03′57″N118°26′41″W / 34.06577°N 118.44480°W / 34.06577; -118.44480